IN8bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IN8bio and other ETFs, options, and stocks.

About INAB

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates for solid and liquid tumors and gamma-delta T cell engagers for cancer and autoimmune diseases. The company was founded by Lawrence S. 

CEO
William T. Ho
CEOWilliam T. Ho
Employees
17
Employees17
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2016
Founded2016
Employees
17
Employees17

INAB Key Statistics

Market cap
12.22M
Market cap12.22M
Price-Earnings ratio
-0.72
Price-Earnings ratio-0.72
Dividend yield
—
Dividend yield—
Average volume
49.36K
Average volume49.36K
High today
$1.38
High today$1.38
Low today
$1.23
Low today$1.23
Open price
$1.36
Open price$1.36
Volume
39.32K
Volume39.32K
52 Week high
$2.73
52 Week high$2.73
52 Week low
$0.88
52 Week low$0.88

Stock Snapshot

The current IN8bio(INAB) stock price is $1.26, with a market capitalization of 12.22M. The stock trades at a price-to-earnings (P/E) ratio of -0.72.

During the trading session on 2026-10-12, IN8bio(INAB) shares reached a daily high of $1.38 and a low of $1.23. At a current price of $1.26, the stock is +2.7% higher than the low and still -8.6% under the high.

Trading volume for IN8bio(INAB) stock has reached 39.32K, versus its average volume of 49.36K.

Over the past 52 weeks, IN8bio(INAB) stock has traded between a high of $2.73 and a low of $0.88.

Over the past 52 weeks, IN8bio(INAB) stock has traded between a high of $2.73 and a low of $0.88.

People also own

Based on the portfolios of people who own INAB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.